1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) MARKET BY PRODUCT TYPE
5.1. Introduction
5.2. Single-Chamber ICD
5.3. Dual-Chamber ICD
5.4. Biventricular ICD
6. IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) MARKET BY PROCEDURE
6.1. Introduction
6.2. Transvenous Implantable Cardioverter Defibrillators (TV-ICDs)
6.3. Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
7. IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) MARKET BY APPLICATION
7.1. Introduction
7.2. Ventricular Arrhythmia
7.3. Heart Failure
7.4. Others
8. IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) MARKET BY END-USER
8.1. Introduction
8.2. Hospitals
8.3. Specialty Clinics
8.4. Ambulatory Surgical Centers (ASC)
9. IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. USA
9.2.2. Canada
9.2.3. Mexico
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Others
9.4. Europe
9.4.1. Germany
9.4.2. France
9.4.3. United Kingdom
9.4.4. Spain
9.4.5. Others
9.5. Middle East and Africa
9.5.1. Saudi Arabia
9.5.2. UAE
9.5.3. Others
9.6. Asia Pacific
9.6.1. China
9.6.2. Japan
9.6.3. India
9.6.4. South Korea
9.6.5. Thailand
9.6.6. Indonesia
9.6.7. Others
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. Medtronic Plc
11.2. Boston Scientific Corporation
11.3. Abbott Laboratories
11.4. Biotronik
11.5. MicroPort Scientific Corporation
11.6. LivaNova PLC
11.7. Impulse Dynamics
12. APPENDIX
12.1. Currency
12.2. Assumptions
12.3. Base and Forecast Years Timeline
12.4. Key benefits for the stakeholders
12.5. Research Methodology
12.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES